coadministered cagrilintide and semaglutide in adults with overweight or obesity Summary of REDEFINE 1 REDEFINE 2 trials CagriSema, presented this week at #ADA2025 and published NEJM: REDEFINE 1: β’ π₯ 3,417 participants with (without diabetes) treated cagrilintide protocol Once-weekly for weight
Pay in 4 interest-free payments of $5.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 1 - Aug 6
01751-7/asset/6309d074-38cb-40bc-984b-962ca1dbd6df/main.assets/gr2b_lrg.jpg)


























